Ozempic and NAION: Check Your Eye Report

Told you have NAION after using Ozempic? Ask your eye doctor to explain the report and care. Keep eye and drug records for a separate claim review.

What is NAION?

NAION involves low blood flow at the front of the eye’s optic nerve. It can cause sudden loss of sight. Ask a doctor what your report means.

The specialist society’s brochure describes this nerve injury and other factors that can matter. The name does not itself show why a particular person developed it or which company is legally responsible.

What signs need care right away?

Sudden loss of sight needs care right away. You cannot tell the cause from symptoms alone. Get an eye check before a claim review.

MedlinePlus advises prompt eye care for sudden loss of vision. The specialist brochure notes that NAION often causes sudden painless loss, but other serious causes can look similar. Do not use pain or a drug history to rule out care.

How is it diagnosed and treated?

An eye specialist checks several findings, not one test alone. Ask what the exam shows and what other causes need checking. Care needs your own clinician’s advice.

The brochure describes checking vision, the optic nerve and other possible causes. It discusses limits of treatment evidence and care for relevant health risks. It does not supply a current personal medicine switch, steroid or surgery plan.

The FDA-hosted Ozempic label also discusses diabetic retinopathy, a different eye condition. Do not change that diagnosis in your record to NAION because a claim website uses the name.

What does the semaglutide research say?

One eye-center study found a link with NAION. It did not prove cause for one person. Other drugs cannot simply be treated as having the same risk.

The 2024 Hathaway author abstract describes selected patients at one specialist service and matched comparisons. Its retrospective design limits causal interpretation.

In June 2025, the European safety committee concluded NAION was a very rare side effect of semaglutide and recommended product-information changes. That is a European regulatory finding about semaglutide, not a U.S. FDA label finding for all drugs.

Who may qualify for a vision claim review?

Have an eye diagnosis and drug records you want checked? Ask a lawyer to assess the facts and law. This page cannot decide acceptance or an award.

The federal transfer order created a separate NAION case group, MDL 3163, rather than including it in the gut group. Case coordination does not prove an individual cause. Tell the lawyer the diagnosis as written.

Later court-management work concerns proof of use and diagnosis and common issues. Those tasks do not make every person with a drug prescription eligible for a payment.

What records should I keep for the next step?

Keep the eye exam, diagnosis and drug dates. Ask about time limits and written fees. Confirm who will receive your files before sending them.

Request missing records from your covered provider. Preserve the onset date you recall and separate it from later exam dates. A master-complaint or expert-motion schedule is not your personal filing deadline.